Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | TYR | P14679 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL11727205 | 0.97 | ACHE (0.48) | ACHECYP3A4HSD17B10ALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9711148 | 0.97 | ACHE (0.48) | ACHECYP3A4HSD17B10ALOX15ALDH1A1 | |
| Bromide SCHEMBL9711176 | 0.97 | ACHE (0.48) | ACHECYP3A4HSD17B10ALOX15ALDH1A1 | |
| Iodide SCHEMBL9711185 | 0.97 | APOBEC3A (0.52) | ACHECYP3A4HSD17B10ALOX15ALDH1A1 | |
| SCHEMBL2489383 | 0.83 | APOBEC3A (0.62) | ACHECA12CA9APOBEC3AAPOBEC3G | |
| SCHEMBL23447424 | 0.82 | APP (0.64) | CYP3A4HSD17B10ALOX15ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6368015 | 0.79 | APOBEC3A (0.59) | ACHEALDH1A1KDM4ECA12CA9 | |
| Iodide SCHEMBL6373433 | 0.79 | APOBEC3A (0.69) | ACHECA12CA9APOBEC3AAPOBEC3G | |
| Hydroquinone SCHEMBL9857917 | 0.75 | ALOX15 (0.89) | ACHECYP3A4HSD17B10ALOX15ALDH1A1 | |
| SCHEMBL13567373 | 0.73 | APOBEC3A (0.53) | ACHECYP3A4ALDH1A1APOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | claimed |
| EP-1904109-B1 | SELF-STERILIZING PRODUCTS | MOLTENI & C (IT) | 2013-04-03 | — | — | EP | claimed |
| EP-1904060-B1 | USE OF PHTHALOCYANINE DERIVATES FOR THE NON-PHOTODYNAMIC TREATMENT OF DISEASES | MOLTENI & C (IT) | 2011-06-01 | — | — | EP | claimed |
| US-20090130049-A1 | Self-Sterilizing Products | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | claimed |
| CN-120504642-A | Synthesis method of NBD fluorescent probe and method for detecting and imaging cysteine in living cells by using same | 浙江大学绍兴研究院 | 2025-08-19 | — | — | CN | disclosed |
| US-9939729-B2 | Resist pattern-forming method | JSR CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9766547-B2 | Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device | FUJIFILM CORPORATION (JP) | 2017-09-19 | — | — | US | disclosed |
| US-9766547-B2 | Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device | FUJIFILM CORPORATION (JP) | 2017-09-19 | — | — | US | disclosed |
| US-9651863-B2 | Pattern forming method, active light sensitive or radiation sensitive resin composition, resist film, method for manufacturing electronic device, and electronic device | FUJIFILM CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9651863-B2 | Pattern forming method, active light sensitive or radiation sensitive resin composition, resist film, method for manufacturing electronic device, and electronic device | FUJIFILM CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-20170075224-A1 | RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20170075224-A1 | RESIST PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2017-03-16 | — | — | US | disclosed |
| US-20150126703-A1 | CATALYZED POLYMERIZATION OF CYCLIC ESTERS AND CYCLIC CARBONATES | UNIVERSITE DE MONS (BE) | 2015-05-07 | — | — | US | disclosed |
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | disclosed |
| US-8663880-B2 | Polymerizable composition for color filter, color filter, and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2014-03-04 | — | — | US | disclosed |
| EP-1904109-B1 | SELF-STERILIZING PRODUCTS | MOLTENI & C (IT) | 2013-04-03 | — | — | EP | disclosed |
| EP-2420871-A1 | POLYMERIZABLE COMPOSITION FOR COLOR FILTER, COLOR FILTER, AND SOLID IMAGING ELEMENT | FUJIFILM Corporation (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20110217637-A1 | POLYMERIZABLE COMPOSITION FOR COLOR FILTER, COLOR FILTER, AND SOLID-STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
| US-20090130049-A1 | Self-Sterilizing Products | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| US-5071965-A | NOVEL TC-99M COMPLEXES | MALLINCKRODT MEDICAL, INC. (US) | 1991-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130049-A1 | Self-Sterilizing Products | NASP, ZP1, SPAG5 | ACHE 4720/4885CYP3A4 1820/4885HSD17B10 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.